Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOTT VAC | VAC | 3.27% |
| BLOOMIN' | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Dental technology leader Sirona Dental Systems, Inc. (SIRO - Snapshot Report) recently announced the expansion of its exclusive distribution agreement with Patterson Companies, Inc. (PDCO - Analyst Report).
Following the amendments, Patterson Companies has become the exclusive U.S. distribution partner for all Sirona products with immediate effect. Patterson Dental, the largest business unit of Patterson Companies, will be the specialty distributor for Sirona.
The agreement provides Patterson Companies with the exclusive U.S. distribution rights for all products manufactured by Sirona. The other distribution dealers associated with Sirona as of June 1, 2012 will continue to receive equipment only until September 1, 2012. However, these dealers can order spare parts for Sirona products for an indefinite time.
Management at Sirona asserts that the expansion of its exclusive distribution agreement with Patterson will improve the company’s marketing management by strengthening its go-to-market strategy. The main focus of this perennial agreement is to expand its presence in the U.S. market and thereby increase revenues. Management also believes that the company is well poised for continued growth in the long run, given its worldwide sales and service infrastructure.
Sirona posted revenues of $231.9 million (up 8% year over year) in the second quarter of fiscal 2012. Revenue in the U.S. increased 4.9% whereas revenues outside the U.S. were up 9.2% (up 13.7% in constant currency terms). The outside revenue growth was boosted by strong sales, specifically in the Asia Pacific.
Sirona is well placed in the international market with Henry Schein, Inc. (HSIC - Snapshot Report) being its principally largest distributor and core partner in Europe. Henry Schein is a global supplier of healthcare products and services to healthcare practitioners based in offices. It operates in the medical, dental and veterinary verticals. Henry Schein is also Sirona’s major partner in Canada.
Sirona is a leading innovator and manufacturer of dentistry products. The company directly competes with DENTSPLY International Inc. (XRAY - Analyst Report).
Sirona currently retains a Zacks #3 Rank, which translates into a short-term Hold rating.
Read the full reports :
Analyst Report on PDCO
Snapshot Report on SIRO
Analyst Report on XRAY
Snapshot Report on HSIC